The U.S. will likely emerge the winner in a "cold currency war" that is heating up, an expert said.Currenciesread more
These box office numbers do not include the cost of production or marketing costs. They also don't count the billions in merchandising that Disney has made over the last...Entertainmentread more
Tariffs are the only instrument left for addressing China's systematic and excessive surpluses on its U.S. trades, writes Michael Ivanovitch.US Economyread more
In its latest attempt to build market credibility, China on Monday launched the Science and Technology Innovation Board, or "STAR Market," on which 25 companies were listed.China Economyread more
When Cathy Hsu and Tony Hsieh wanted to build an English language app for Chinese children, they decided to follow Facebook and Google's lead.Start-upsread more
Stocks in Asia traded lower on Monday afternoon, as a Nasdaq-style technology board on the Shanghai Stock Exchange marked its debut.Asia Marketsread more
Instagram began tests that hide "like" counts on posts. That means influencers who market products on Instagram will have to rely on different metrics to show success.Technologyread more
Peter Neupert worked for Microsoft and Amazon-backed Drugstore.com, where he got to know Jeff Bezos. He now advises start-ups.Technologyread more
The firing of the tear gas was the latest confrontation between police and protesters who have taken to the streets for over a month to fight a proposed extradition bill and...China Politicsread more
Last week shows that oil prices are not the indicator for Middle East tensions they once were, and worries about global demand and growing U.S. production has changed that...Market Insiderread more
Facebook Vice President David Marcus is the face of the company's Libra digital currency, but the original driving force was a 26-year-old female corporate-development...Technologyread more
As fear mounts around the global impact of Zika, one of Wall Street's most closely followed bulls has an ominous message about how the health crisis could impact markets in the weeks to come.
As U.S. health officials move to halt the virus' spread in Miami, where the disease has raged for weeks, markets have been surprisingly placid in the face of the growing health crisis. Based on previous circumstances, however, Canaccord Genuity's chief market strategist told CNBC that could easily turn on a dime.
"When we study 2014, we were dealing with many of the same issues that had yet to cause a correction," Tony Dwyer told CNBC's "Fast Money" this week.
In 2014, the S&P 500 index experienced a sharp and sudden correction, and according to Dwyer, many of the same ingredients that contributed to the turmoil are bubbling beneath the surface of the current rally. Those factors include persistent fears about the Federal Reserve's next policy move, a weak euro zone and falling oil prices.
Two years ago, "the straw that broke the camel's back was the first confirmed case of the Ebola virus in the U.S.," Dwyer said.
The analyst added that in October of 2014, stocks were trading near all-time highs amid low volatility. But that was before the Ebola crisis helped trigger a deep slide in U.S. markets. Ebola fears help shove blue-chip and tech shares into correction territory that year.
"The only thing scarier than your own health fear is that of your children," noted Dwyer when discussing how a health scare has the ability to shake investor confidence. Zika is a particular concern for pregnant women, who may give birth to children with birth defects if exposed to the virus.
As it stands, Dwyer has been calling for a market correction since turning neutral on U.S. stocks back in mid-July. Noting that stocks have floated in a historically narrow range, Dwyer said a blitz of earnings results, economic data and global central bank meetings have yet to push the market out of its comfortable range — or lead to a sharp downturn.
Dwyer went on to say that perhaps Zika — compounded with Italian bank issues, a potentially more hawkish Fed and energy price weakness — could be enough to spook investors. The risk factors may cause a correction similar to the one that occurred around the Ebola scare, he added.
The strategist noted the first U.S. Ebola case was reported on September 30, 2014. From there, the S&P 500 slipped 1.7 percent off its peak. By the time the third U.S. case was diagnosed, the market was already down 7 percent.
"Obviously, no two situations are exactly alike, but this is pretty close," concluded Dwyer. "I'm not looking for anything like a 10 percent decline, and the market isn't showing me we're going to get it, but this could be the catalyst when we've been looking for a catalyst."